Fluorodeoxyglucose, FDG, is the most commonly used PET
radiopharmaceutical. IBA Molecular understands the impact an FDG PET
scan can have on the care of patients around the world. As a result, we have
built the only global FDG distribution network, ensuring that our customers can
properly diagnose and stage their patients disease.
Currently, our distribution network expands throughout:
- Belgium
- France
- Germany
- India
- Italy
- Spain
- United Kingdom
- United States
In addition to our distribution network, IBA Molecular offers effective programs
and services aimed at transmitting reports and images to your referrring
physician, as well as education programs for administrators, marketing staff,
technologists, radiologist and physicians.
For more information, please contact the sales representative in your country.